Long-term outcomes of high-dose conbercept treatment for myopic cho-roidal neovascularisation and idiopathic choroidal neovascularisation.
Sign Up to like & getrecommendations! Published in 2023 at "Ophthalmic research"
DOI: 10.1159/000529342
Abstract: INTRODUCTION To report 2-year outcomes of intravitreal injection of high-dose conbercept (1 mg 2+PRN scheme) for subjects with myopic choroidal neovascularization (mCNV) and idiopathic choroidal neovascularization (iCNV) by optical coherence tomography angi-ography (OCTA) follow-up. METHODS… read more here.
Keywords: neovascularisation; idiopathic choroidal; group; dose conbercept ... See more keywords